LSTM Home > LSTM Research > LSTM Online Archive

Linezolid for drug-resistant tuberculosis

Tools

Singh, Bhagteshwar, Cocker, Derek, Ryan, Hannah and Sloan, Derek (2017) 'Linezolid for drug-resistant tuberculosis'. Cochrane Database of Systematic Reviews, Vol 11, Issue CD012836.

Preview

Text
Cochrane_Library_Singh_et_al-2017.pdf - Published Version
Available under License Creative Commons Attribution.
Download (148kB) | Preview

Official URL: http://www.cochranelibrary.com/

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group

Item Type:	Article
Subjects:	QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268 Antitubercular agents. Antitubercular antibiotics QV Pharmacology > QV 38 Drug action. QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WB Practice of Medicine > WB 102 Clinical medicine WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 360 Drug therapy
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1002/14651858.cd012836
SWORD Depositor:	JISC Pubrouter
Depositing User:	Stacy Murtagh
Date Deposited:	16 Nov 2017 11:12
Last Modified:	22 Nov 2018 10:11
URI:	https://archive.lstmed.ac.uk/id/eprint/7828

Statistics

View details

Actions (login required)

Edit Item